OpenEvidence reportedly reaches $15B valuation

OpenEvidence reportedly raised $250 million at a $15 billion valuation, up from $12 billion in January, according to Business Insider’s report. The round is a market signal, not clinical validation; teams evaluating healthcare AI should keep Enveda’s clinical-capital gate in view before treating adoption or valuation as evidence of safe deployment.